Analysis of risk factors and prevention strategies of post-ERCP pancreatitis

被引:5
|
作者
Lin, Y. [1 ]
Liu, X. [1 ]
Ca, D. -Q. [1 ]
Tang, J. -H. [1 ]
Wen, J. -J. [1 ]
Li, T. -F. [2 ]
Liu, P. -F. [2 ]
Xia, T. -S. [2 ]
机构
[1] Nanchang Univ, Affiliated Ganzhou Hosp, Dept Gastroenterol, Nanchang, Jiangxi, Peoples R China
[2] Southeast Univ, Coll Med, Jiangyin Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China
关键词
ERCP; PEP; Risk factors; Prevention;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To analyze the relevant risk factors and preventive measures for post-endoscopic retrograde cholangiopancrea-to-graphy (post-ERCP) pancreatitis (PEP) so as to improve the diagnosis and treatment levels of ERCP, thus reducing the prevalence rate of PEP. PATIENTS AND METHODS: The clinical data of 278 patients receiving ERCP from January 2014 to December 2016 were retrospectively analyzed. First, the univariate analysis was conducted for the factors such as gender, age, diameter of common bile duct, whether development occurred in the pancreatic duct and other factors. Then, the multivariate logistic regression analysis was performed for factors showing statistical significance in the univariate analysis so as to analyze the independent risk factors for PEP. RESULTS: The success rate of ERCP included in the study was 97.12%. The prevalence rate of PEP was 8.27%. Univariate analysis results showed that the prevalence rate of PEP in the group of patients younger than 60 years old was higher than that in the group of patients older than 60 years old (14.14% vs. 5.03%, p = 0.016); the prevalence rate of PEP in the group of patients with intubation difficulty was higher than that in the group of patients without intubation difficulty (19.61% vs. 5.73%, p = 0.004); the prevalence rate of PEP in the group of patients with operation time more than 60 min was higher than that in the group of patients with operation time less than 60 min (18.60% vs. 6.38%, p = 0.034); the prevalence rate of PEP in the group of patients with the pancreatic duct development was higher than that in the group of patients without the pancreatic duct development (50% vs. 6.72%, p < 0.001); the prevalence rate of PEP in the group of patients placed with nasobiliary drainage catheters was not higher than that in the group of patients not placed with nasobiliary drainage catheters (18.00% vs. 2.81%, p < 0.001). The above five relevant factors were included in the logistic regression equation for the multivariate analysis, which showed that the age less than 60 years old (p = 0.002) and the pancreatic duct development (p = 0.004) were independent risk factors for PEP, and nasobiliary drainage (p = 0.003) was a protective factor for PEP. CONCLUSIONS: The occurrence of PEP is associated with the age less than 60 years old, the pancreatic duct development, intubation difficulty and overlong operation time. Among them, the pancreatic duct development and the age less than 60 years old are independent risk factors for PEP. Placing nasobiliary drainage catheters after operation, avoiding the pancreatic duct development, improving the success rate of intubation, reducing ERCP operation time and other methods, can effectively reduce the occurrence of PEP.
引用
收藏
页码:5185 / 5190
页数:6
相关论文
共 50 条
  • [1] Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Gwang Ha
    Eum, Jae Sup
    Lee, Sun Mi
    Song, Geun Am
    Kim, Dong Uk
    Kim, Il Doo
    Cho, Mong
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (04) : E11 - E18
  • [2] Nafamostat Mesilate in the Prevention of Post-ERCP Pancreatitis and Risk Factors for Post-ERCP Pancreattis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Hyung Wook
    Park, Chan Ho
    Bae, Yong Mock
    Lee, Sang-Yong
    Park, Hyoung-Yoel
    Kim, Yong Wuk
    Lee, Jae Seung
    Kim, Jeong Yeol
    Heo, Jeung Ho
    Jeong, Eul Jo
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB269 - AB269
  • [3] Incidence, risk factors, and prevention of post-ERCP pancreatitis
    Cooper, Scott T.
    Slivka, Adam
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2007, 36 (02) : 259 - +
  • [4] Risk factors for post-ERCP pancreatitis
    Kadayifci, A.
    ENDOSCOPY, 2008, 40 (01) : 81 - 81
  • [5] Post-ERCP pancreatitis: Prospective analysis of risk factors
    Rabenstein, T
    Radespiel-Troeger, M
    Siebert, S
    Hochberger, J
    Muehldorfer, S
    Nusko, G
    Schneider, TH
    Hahn, E
    GASTROINTESTINAL ENDOSCOPY, 2002, 55 (05) : AB156 - AB156
  • [6] Prevention of Post-ERCP Pancreatitis
    Jennifer Maranki
    Paul Yeaton
    Current Gastroenterology Reports, 2013, 15 (11)
  • [7] Prevention of Post-ERCP Pancreatitis
    Donnellan, F.
    Byrne, Michael F.
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2012, 2012
  • [8] Prevention of post-ERCP pancreatitis
    Baron, T. H.
    Irani, S.
    MINERVA MEDICA, 2014, 105 (02) : 129 - 136
  • [9] Prevention of post-ERCP pancreatitis
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (12): : 850 - 850
  • [10] Prevention of post-ERCP pancreatitis
    Haber, GB
    GASTROINTESTINAL ENDOSCOPY, 2000, 51 (01) : 100 - 103